Molecular Tests for Risk-Stratifying Cytologically Indeterminate Thyroid Nodules: An Overview of Commercially Available Testing Platforms in the United States
نویسندگان
چکیده
The past decade has witnessed significant advances in the application of molecular diagnostics for pre-operative risk-stratification cytologically indeterminate thyroid nodules. tests that are currently marketed United States this purpose combine aspects tumor genotyping with gene and/or microRNA expression profiling. This review compares general methodology and clinical validation studies three offered States: ThyroSeq v3, Afirma GSC Xpression Atlas, ThyGeNEXT/ThyraMIR.
منابع مشابه
Local molecular analysis of indeterminate thyroid nodules
BACKGROUND Thyroid nodules are common but only a minority are malignant. Molecular testing can assist in helping determine whether indeterminate nodules are suspicious for malignancy or benign. The objective of the study was to determine if the analysis of mutations (BRAF, NRAS, KRAS and HRAS) using readily available molecular techniques can help better classify indeterminate thyroid nodules. ...
متن کاملCost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
CONTEXT Patients with thyroid nodules of indeterminate cytology undergo diagnostic surgery according to current guidelines. In 75% of patients, the nodule is benign. In these patients, surgery was unnecessary and unbeneficial because complications may occur. Preoperative fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) was found to have a very high negative predi...
متن کاملUtility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules
BACKGROUND Fine needle aspiration (FNA) is widely utilized for evaluation of patients with thyroid nodules. However, approximately 30% are indeterminate for malignancy. Recently, a mutation in the BRAF gene has been reported to be the most common genetic event in papillary thyroid carcinoma (PTC). In this retrospective study, we assessed the utility of BRAF V600E mutation detection for refining...
متن کاملAn independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
CONTEXT Molecular markers hold the promise of improved diagnostic yield in thyroid fine-needle biopsy. The Afirma gene expression classifier (GEC), available commercially, reports a negative predictive value of 94% in the diagnosis of benign nodules after indeterminate cytology. However, there are currently no independent studies of the performance of this assay. OBJECTIVE The aim was to asse...
متن کاملDigital gene expression profiling of a series of cytologically indeterminate thyroid nodules.
BACKGROUND Fine-needle aspiration cytology (FNAC) has been widely accepted as the most crucial step in the preoperative assessment of thyroid nodules. Testing for the expression of specific genes should improve the accuracy of FNAC diagnosis, especially when it is performed in samples with indeterminate cytology. METHODS In total, 69 consecutive FNACs that had both cytologic and histologic di...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of molecular pathology
سال: 2021
ISSN: ['2673-5261']
DOI: https://doi.org/10.3390/jmp2020014